Defining quality in thyroid FNA
Open Access
- 28 December 2021
- journal article
- editorial
- Published by Wiley in Cancer Cytopathology
- Vol. 130 (4) , 246-247
Abstract
Combining cytologic and molecular data may provide a useful approach to defining quality in thyroid fine‐needle aspiration. The article in this issue by Gokozan and colleagues provides an excellent starting point for defining quality metrics that incorporate both cytologic and molecular results to ensure patients receive the best care.Keywords
This publication has 3 references indexed in Scilit:
- Combining molecular testing and the Bethesda category III:VI ratio for thyroid fine‐needle aspirates: A quality‐assurance metric for evaluating diagnostic performance in a cytopathology laboratoryCancer Cytopathology, 2021
- The Bethesda System for Reporting Thyroid Cytopathology2018
- The atypia of undetermined significance/follicular lesion of undetermined significance:malignant ratioCancer Cytopathology, 2011